HopeStage
Back to all studies
CompletedNCT02845453

Quetiapine Added to Usual Care for Youth With Mood and Substance Use Challenges

About this titleRead the official source — NCT02845453
Medication studyAges 15–24United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 15 years to 24 years.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 20, 2017
Recruitment status
Completed
Enrollment listed in the registry
24
Sponsor
Boston Medical Center
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 15 Years to 24 Years
Official registry ID
NCT02845453
Official title
Show the full official title

A Randomized Controlled Trial of Quetiapine for the Treatment of Youth With Co-occurring Substance Use Disorders and Severe Mood Dysregulation

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Boston Medical Center, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Quetiapine.

Who was this study for?

Listed age limits: 15 years to 24 years.

Want to explore more studies?

Explore studies